Upgrade

Finvezto Toolkit

Orchid Pharma Q2 FY27: revenue up 76.3% to ₹341 Cr, net profit ₹29 Cr

Results · 17 Nov 2026 · Orchid Pharma (ORCHPHARMA)

Q2 FY27 results
Q2 FY27₹ CrYoY
Revenue341+76.3%
Operating profit24-
Net profit29-

In Q2 FY27, revenue from operations grew approximately 14% year-on-year to INR341 crores, gross margin rose to around 39%, and EBITDA grew 148% to INR52 crores.

Q2 FY27 profit after tax was INR28.6 crores despite a nearly 30% year-on-year rise in fuel and energy costs and two one-time accounting items of INR5 crores each.

EXBLIFEP royalty and milestone receipts reached an annual run rate of $3 million to $4 million, with recent licensing deals signed for Russia and Latin America.

Company page · Results tracker

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.